Hector Rodriguez

Hector Rodriguez is a seasoned professional with extensive experience in biochemistry and biology, currently serving as the Vice President of New Targets at Kardigan since February 2025. Prior roles include Vice President of Biology at BridgeBio from July 2017 to January 2025, and Senior Director of Biology at MyoKardia from July 2012 to April 2017. Serving as a Scientific Consultant at Edgewise Therapeutics since May 2017, Hector has also established foundational groups and infrastructure at Calithera Biosciences and Arresto BioSciences. Earlier career highlights include managing protein production at Cytokinetics, Inc. and completing a Ph.D. in Chemistry at the University of California, Santa Cruz, where graduate studies were conducted under Dr. Lydia M.